Replies to post #585166 on NorthWest Biotherapeutics Inc (NWBO)

[Nix59]

We all get it. We all want it. For MANY reasons and the frustration is high on crossing the goal line. Feel blessed that we knew before the real market and ride the tide until bliss for all longs and most importantly the cancer tumor survivors!

[HappyLibrarian]

No one has a problem with an extra one or two months if that all it really is. With NWBO a process that should take weeks (according to the management, not us) can turn into over a year.

At this point MHRA either supports DCVax-L or they don’t. They know the cost in lives of every month this treatment is unavailable and DCVax-L’s Phase 3 trial was supposedly an NHS priority and the product is being homegrown in the UK. If they are looking for an excuse to impose a delay then as bureaucrats they can always find it and no amount of delay will buy immunity from that. By contrast they are looking for a reason to make approval happen then as with the COVID-19 vaccines, they can do it and adding 1 or 2 months of NWBO-style OCD tweaking will not matter.

Maybe the dynamic is different with the FDA

[biosectinvestor]

Not a lot of other examples of similar treatments approved in terms of autologous treatments and this is very complex. But I agree wholeheartedly, most important is getting it right. Rushing is not really necessary at this stage though appropriate efforts to carefully but urgently expedite whenever possible are very much appreciated. Rushing can lead to mistakes but careful expediting whenever possible and appropriate is a what I am happy to see. I have no doubt that is what they are likely doing.

[CrashOverride]

We all want the stock to be at $50 instead of $0.50.

In my personal opinion it has been derisked. I don't know everything because I am not an insider. Management remain heavily invested in the outcome while meeting all milestones. For that reason I have no concerns.